References
1. Singhi P. Infectious causes of seizures and epilepsy in the developing world. Dev Med Child Neurol. 2011;53(7):600-9. doi: 10.1111/j.1469-8749.2011.03928.x.
2. Lowenstein DH, Walker M, Waterhouse E. Status epilepticus in the setting of acute encephalitis. Epilepsy Curr. 2014;14(1 Suppl):43-9. doi: 10.5698/1535-7511-14.s2.43.
3. Roos KL. Neurologic Complications of Lyme Disease. Continuum (Minneap Minn). 2021;27(4):1040-50. doi: 10.1212/CON.0000000000001015.
4. Wilske B. Epidemiology and diagnosis of Lyme borreliosis. Ann Med. 2005;37(8):568-79. doi: 10.1080/07853890500431934.
5. Schotthoefer AM, Frost HM. Ecology and Epidemiology of Lyme Borreliosis. Clin Lab Med. 2015;35(4):723-43. doi: 10.1016/j.cll.2015.08.003.
6. Allen NM, Jungbluth H. Lyme Neuroborreliosis: A Potentially Preventable Cause of Stroke. J Pediatr. 2016;170:334-e1. doi: 10.1016/j.jpeds.2015.11.077.
7. Wendling D, Sevrin P, Bouchaud-Chabot A, Chabroux A, Toussirot E, Bardin T, et al. Parsonage-Turner syndrome revealing Lyme borreliosis. Joint Bone Spine. 2009;76(2):202-4. doi: 10.1016/j.jbspin.2008.07.013.
8. Fallon BA, Schwartzberg M, Bransfield R, Zimmerman B, Scotti A, Weber CA, et al. Late-stage neuropsychiatric Lyme borreliosis. Differential diagnosis and treatment. Psychosomatics. 1995;36(3):295-300. doi: 10.1016/S0033-3182(95)71669-3.
9. Blanc F, Gebly. [Neurologic and psychiatric manifestations of Lyme disease]. Med Mal Infect. 2007;37(7-8):435-45. doi: 10.1016/j.medmal.2006.01.025.
10. Mullegger RR, Glatz M. Skin manifestations of lyme borreliosis: diagnosis and management. Am J Clin Dermatol. 2008;9(6):355-68. doi: 10.2165/0128071-200809060-00002.
11. Kostic T, Momcilovic S, Perisic ZD, Apostolovic SR, Cvetkovic J, Jovanovic A, et al. Manifestations of Lyme carditis. Int J Cardiol. 2017;232:24-32. doi: 10.1016/j.ijcard.2016.12.169.
12. Strle F, Stanek G. Clinical manifestations and diagnosis of lyme borreliosis. Curr Probl Dermatol. 2009;37:51-110. doi: 10.1159/000213070.
13. Xing J, Radkay L, Monaco SE, Roth CG, Pantanowitz L. Cerebrospinal Fluid Cytology of Lyme Neuroborreliosis: A Report of 3 Cases with Literature Review. Acta Cytol. 2015;59(4):339-44. doi: 10.1159/000439160.
14. Morrison DG, Phuah HK, Reddy AT, Dure LS, Kline LB. Ophthalmologic involvement in the syndrome of headache, neurologic deficits, and cerebrospinal fluid lymphocytosis. Ophthalmology. 2003;110(1):115-8. doi: 10.1016/s0161-6420(02)01444-6.
15. Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay. Clin Infect Dis. 2011;53(6):541-7. doi: 10.1093/cid/cir464.
16. Djukic M, Schmidt-Samoa C, Lange P, Spreer A, Neubieser K, Eiffert H, et al. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis. J Neurol. 2012;259(4):630-6. doi: 10.1007/s00415-011-6221-8.
17. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8-16, e1-4. doi: 10.1111/j.1468-1331.2009.02862.x.
18. Remy MM, Schobi N, Kottanattu L, Pfister S, Duppenthaler A, Suter-Riniker F. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study. J Neuroinflammation. 2017;14(1):173. doi: 10.1186/s12974-017-0948-9.
19. Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for lyme disease. Clin Infect Dis. 2008;47(2):188-95. doi: 10.1086/589242.
20. Baunbaek Egelund G, Ertner G, Langholz Kristensen K, Vestergaard Jensen A, Benfield TL, Brandt CT. Cerebrospinal fluid pleocytosis in infectious and noninfectious central nervous system disease: A retrospective cohort study. Medicine (Baltimore). 2017;96(18):e6686. doi: 10.1097/MD.0000000000006686.
21. Halperin JJ. Diagnosis and management of Lyme neuroborreliosis. Expert Rev Anti Infect Ther. 2018;16(1):5-11. doi: 10.1080/14787210.2018.1417836.